Pediatric Infection and Vaccine
- 제15권2호
- /
- Pages.115-120
- /
- 2008
- /
- 2384-1079(pISSN)
- /
- 2384-1087(eISSN)
한국에서 A형간염 백신(GlaxoSmithKline Biologicals' $Havrix^{TM}$ )의 시판 후 조사
Post-Marketing Surveillance Study of Hepatitis A Vaccine in Korean Population
- 최재원 (창원파티마병원 소아청소년과) ;
- 김명석 (창원파티마병원 소아청소년과) ;
- 마상혁 (창원파티마병원 소아청소년과) ;
- 강진한 (가톨릭대학교 의과대학 소아청소년과학 교실) ;
- ;
- ;
- ;
- 한국 A형간염 백신 시판 후 연구 그룹 (한국 A형간염 백신 시판 후 연구 그룹)
- Choi, Jae-Won (Department of Pediatrics, Fatima Hospital) ;
- Kim, Myoung-Seok (Department of Pediatrics, Fatima Hospital) ;
- Ma, Sang-Hyuk (Department of Pediatrics, Fatima Hospital) ;
- Kang, Jin-Han (Department of Pediatrics, Our Lady of Mercy Hospital, College of Medicine The Catholic University) ;
- Ok, Jin-Ju (GlaxoSmithKline Biologicals) ;
- Ng, Timothy L. (GlaxoSmithKline Biologicals) ;
- Bock, Hans L. (GlaxoSmithKline Biologicals) ;
- HavrixTM PMS Korean study group, (Group Members Listed at the End of Paper)
- 발행 : 2008.12.25
초록
목 적 : 본 시판 후 조사는 한국인에게 투여한 A형 간염 백신(GlaxoSmithKline Biologicals'
Purpose : This post-marketing surveillance (PMS) study was conducted in Korea to assess the safety and reactogenicity of hepatitis A vaccine (GlaxoSmithKlineBiologicals'